101 related articles for article (PubMed ID: 32122859)
21. The combination of natural compounds Crila and epigallocatechin gallate showed enhanced antiproliferative effects on human uterine fibroid cells compared with single treatments.
Bai T; Ali M; Somers B; Yang Q; McKinney S; Al-Hendy A
F S Sci; 2023 Nov; 4(4):341-349. PubMed ID: 37739343
[TBL] [Abstract][Full Text] [Related]
22. Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1.
Chuang TY; Min J; Wu HL; McCrary C; Layman LC; Diamond MP; Azziz R; Al-Hendy A; Chen YH
Reprod Sci; 2017 Jul; 24(7):1005-1013. PubMed ID: 27799459
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of proliferation and transforming growth factor beta3 protein expression by peroxisome proliferators-activated receptor gamma ligands in human uterine leiomyoma cells.
Zhang CH; Wen ZQ; Li JF; Li CZ; Shi M; Yang GW; Lan SM; Zhu Y; Wang F; Zhang YJ; Wang YY; Zhang H
Chin Med J (Engl); 2008 Jan; 121(2):166-71. PubMed ID: 18272045
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotective effects of neolignans isolated from Magnoliae Cortex against glutamate-induced apoptotic stimuli in HT22 cells.
Yang EJ; Lee JY; Park SH; Lee T; Song KS
Food Chem Toxicol; 2013 Jun; 56():304-12. PubMed ID: 23454146
[TBL] [Abstract][Full Text] [Related]
25. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
Sangkomkamhang US; Lumbiganon P; Laopaiboon M; Mol BW
Cochrane Database Syst Rev; 2013 Feb; (2):CD008994. PubMed ID: 23450594
[TBL] [Abstract][Full Text] [Related]
26. A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells.
Chen W; Ohara N; Wang J; Xu Q; Liu J; Morikawa A; Sasaki H; Yoshida S; Demanno DA; Chwalisz K; Maruo T
J Clin Endocrinol Metab; 2006 Apr; 91(4):1296-304. PubMed ID: 16464945
[TBL] [Abstract][Full Text] [Related]
27. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
28. Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells.
Ohara N; Morikawa A; Chen W; Wang J; DeManno DA; Chwalisz K; Maruo T
Reprod Sci; 2007 Dec; 14(8 Suppl):20-7. PubMed ID: 18089606
[TBL] [Abstract][Full Text] [Related]
29. Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma.
Walker CL; Burroughs KD; Davis B; Sowell K; Everitt JI; Fuchs-Young R
J Soc Gynecol Investig; 2000; 7(4):249-56. PubMed ID: 10964025
[TBL] [Abstract][Full Text] [Related]
30. Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model.
Koohestani F; Qiang W; MacNeill AL; Druschitz SA; Serna VA; Adur M; Kurita T; Nowak RA
Hum Reprod; 2016 Jul; 31(7):1540-51. PubMed ID: 27130615
[TBL] [Abstract][Full Text] [Related]
31. Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-kappaB.
Lee SY; Cho JS; Yuk DY; Moon DC; Jung JK; Yoo HS; Lee YM; Han SB; Oh KW; Hong JT
J Pharmacol Sci; 2009 Oct; 111(2):124-36. PubMed ID: 19834284
[TBL] [Abstract][Full Text] [Related]
32. Ginsenoside Rb1 inhibits proliferation and promotes apoptosis by regulating HMGB1 in uterine fibroid cells.
Zhang J; Wang J; Wu X; Wei Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2967-2971. PubMed ID: 31313594
[TBL] [Abstract][Full Text] [Related]
33. Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism.
Lützen U; Zhao Y; Lucht K; Zuhayra M; Marx M; Cascorbi I; Culman J
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):37-48. PubMed ID: 27664035
[TBL] [Abstract][Full Text] [Related]
34. Uterine fibroid therapy: the pharmacokinetic considerations.
Ali M; Al-Hendy A
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):887-889. PubMed ID: 30058386
[No Abstract] [Full Text] [Related]
35. Salinomycin inhibited cell proliferation and induced apoptosis in human uterine leiomyoma cells.
Lee HG; Lee JM; Shin SJ; Kwon SH; Lee GS; Song CH; Choi ES; Cha SD; Cho CH
Obstet Gynecol Sci; 2014 Nov; 57(6):501-6. PubMed ID: 25469339
[TBL] [Abstract][Full Text] [Related]
36. Effects of miRNA-197 overexpression on proliferation, apoptosis and migration in levonorgestrel treated uterine leiomyoma cells.
Wu X; Ling J; Fu Z; Ji C; Wu J; Xu Q
Biomed Pharmacother; 2015 Apr; 71():1-6. PubMed ID: 25960207
[TBL] [Abstract][Full Text] [Related]
37. Fas and its ligand, caspases, and bcl-2 expression in gonadotropin-releasing hormone agonist-treated uterine leiomyoma.
Huang SC; Tang MJ; Hsu KF; Cheng YM; Chou CY
J Clin Endocrinol Metab; 2002 Oct; 87(10):4580-6. PubMed ID: 12364438
[TBL] [Abstract][Full Text] [Related]
38. The role of atorvastatin in suppressing tumor growth of uterine fibroids.
Shen Z; Li S; Sheng B; Shen Q; Sun LZ; Zhu H; Zhu X
J Transl Med; 2018 Mar; 16(1):53. PubMed ID: 29523174
[TBL] [Abstract][Full Text] [Related]
39. Profibrotic interleukin-33 is correlated with uterine leiomyoma tumour burden.
Santulli P; Even M; Chouzenoux S; Millischer AE; Borghese B; de Ziegler D; Batteux F; Chapron C
Hum Reprod; 2013 Aug; 28(8):2126-33. PubMed ID: 23739220
[TBL] [Abstract][Full Text] [Related]
40. Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells.
Wang J; Ohara N; Takekida S; Xu Q; Maruo T
Hum Reprod; 2005 Jun; 20(6):1456-65. PubMed ID: 15760954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
